Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.12
Delayed Data
As of 4:00pm ET
 -0.04 / -0.56%
Today’s Change
6.71
Today|||52-Week Range
11.93
-13.17%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close7.16
Today’s open7.12
Day’s range7.03 - 7.18
Volume113,325
Average volume (3 months)419,329
Market cap$289.9M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-473.39%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+16.26%
P/E ratio4.4
Price/Sales1.97
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...-0.20-1.32%
GLYCGlycoMimetics Inc+0.34+1.96%
TLGTTeligent Inc-0.06-1.67%
DEPODepomed Inc-0.10-1.47%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$174.2M
Annual profit (last year)$67.8M
Net profit margin38.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Operating Officer &
Executive Vice President
Gregory J. Divis
Corporate headquarters
Dublin, Dublin

Forecasts